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Muscle wasting 
Muscle wasting was assessed in 
four studies [2, 6, 7, 8] with dual x-
ray absorptiometry (DXA).  
Exercise intervention groups 
showed decreases in muscle 
wasting.  
Usual care group results showed 
continuous muscle wasting. 
The Effects of Strength Training on Muscle Wasting, Fat Mass and Quality of Life in Men with 
Prostate Cancer Undergoing Androgen Deprivation Therapy: a Meta-Analysis.
Background
• In 2013, the probability of a man developing prostate 
cancer (PCa) was 1 in 6, sitting on top of the charts as 
the single most common area for men to develop 
cancer [4]. 
• The most common form of treatment in New Zealand 
is a funded prescription medicine called Zoladex 
(Goserelin), an anti androgen medication that reduces 
the production of testosterone that can fuel the growth 
of the cancer. 
• Suppression of testosterone production can be related 
with considerable side effects including muscle atrophy 
(sarcopenia/wasting), changes in weight (typically an 
increase in weight from oestrogen levels dominating in 
the body due to the lack of testosterone production). 
• Physical activity focussing on strength training in 
particular has been proposed as a favourable strategy 
to reverse the side effects of Androgen deprivation 
therapy (ADT), especially that of muscle wasting and 
changes in body composition.  
The aim of this meta-analysis is to synthesise the existing 
evidence of the effects of strength training on the 
reduction of muscle wasting, quality of life and fat mass in 
 men with Prostate cancer. 
Methods
• A thorough literature search for 12-16 week strength 
training intervention trials with men with PCa published 
between 2008 and 2018, was performed using 
computerised searches on the databases; Ebscohost, 
Proquest, Scivers, Mendely, PUBmed, Medline Sport 
discus and Google Scholar. 
• The database searches produced 5,650 articles which 
were then accessed for eligibility by using titles and 
abstracts. 4,096 articles were then excluded from the 
search after not meeting the relative inclusion criteria 
• Leaving 25 studies for review. Of the 25 articles, 19 
articles were excluded after not meeting the full inclusion 
criteria. Leaving 6 articles which were relevant to 
intervention trials using strength training to access muscle 
wasting, quality of life and fat mass, along with other 
intervention modalities, among men with PCa. 
• The studies included 453 male patients, of which 215 
men were allocated into an exercise intervention group to 
complete a strength training regime over a period of 
12-16 weeks. The studies included men that were 
initiating their ADT treatment or were currently being 
treated with ADT. 
• All data retrieved was analysed to find baseline and 
intervention results in relation to muscle wasting, quality 
of life and fat mass. Each study analysed reported their 
data results with p value was used to interpret all data to 
find differences between mean pre and post values of 
intervention and usual care groups [5]. A p value of less 
than 0.05 was considered a significant difference for each 
of the reviewed studies.
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Overall findings
Quality of life 
Quality of life was measured in four 
studies [1,2,6,7] with The Medical 
Outcomes Study 36-Item Short 
Form Health Survey (SF-36). 
Results showed that training had a 
positive effect on quality of life in 
the exercise group.  
Quality of life did not improve in 
usual care groups.
Fat mass 
Three studies assessed fat mass 
[2, 5, 8]. Fat mass were assessed 
by DXA.  
Results from the exercise group 
show a very slight decrease in fat 
mass. Fat mass was maintained 
but did not increase over the period 
of the study.  
Usual care groups continued to 
show increases in fat mass over 
the period of the study.
Conclusion
In the current meta-analysis, we were able to conclude that strength training is a beneficial 
approach to decreasing muscle wasting, and improving quality of life 
Further study will need to be completed to determine whether there is a clear improvement 
in reduction of fat mass in patients with PCa. 
Strength training should be incorporated into cancer rehabilitation programmes for men 
diagnosed with prostate cancer and undergoing ADT as it shows to have a positive effect 
on adverse effects of ADT. 
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